MedTrace Logo

Evaluation of Two Marketed Multifocal Contact Lenses

NCT03322423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2019-01-08

Study results available
· View outcomes & findings →

Summary

This is a single-masked, randomized, cross-over, dispensing, 6- visit pilot study. The purpose of this clinical study is to evaluate the performance of two marketed multifocal lenses.

Conditions

  • Visual Performance

Interventions

DEVICE

Multifocal Contact Lens 1

Dailies Total 1 Multifocal Contact Lens

DEVICE

Multifocal Contact Lens 2

Biotrue ONEday for Presbyopia Contact Lenses

DEVICE

Spherical Contact Lens 2

BioTrue ONEDay Spherical

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-11
Primary Completion
2017-11-04
Completion
2017-11-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03322423 on ClinicalTrials.gov